A lithium blood test measures the amount of lithium in the bloodstream, usually to make sure bipolar medication is working without reaching a dangerous level. Lithium can be very effective for mood stabilization, but the safe dose range is narrow. A dose that is too low may not prevent mania or depression well enough, while a level that is too high can cause tremor, vomiting, confusion, kidney stress, seizures, or life-threatening toxicity.
The result is usually reported in mmol/L or mEq/L. For lithium, these numbers are practically the same. Timing is critical because lithium levels rise and fall after each dose. Most routine monitoring uses a trough level, usually drawn about 12 hours after the last dose. The number should always be interpreted with the dose schedule, symptoms, kidney function, fluid balance, sodium intake, interacting medicines, and the reason lithium is being used.
- A usual maintenance target for many adults is about 0.6–0.8 mmol/L, but some people need a lower or higher individualized range.
- A level around 0.8–1.0 mmol/L may be used for relapse, ongoing symptoms, or acute treatment when benefits outweigh side effects.
- Lithium toxicity becomes a concern around 1.5 mmol/L and above, but symptoms can sometimes occur at lower levels.
- The test is usually drawn about 12 hours after the last dose, just before the next scheduled dose.
- Kidney function, thyroid function, calcium, and electrolytes are usually monitored along with lithium during long-term treatment.
Table of Contents
- What the Lithium Blood Test Measures
- Therapeutic Range and Target Levels
- How and When the Test Is Done
- High, Low, and Toxic Lithium Results
- Why Lithium Levels Change
- Other Tests Used With Lithium Monitoring
- What to Do With Lithium Blood Test Results
What the Lithium Blood Test Measures
A lithium blood test measures the concentration of lithium in serum or plasma. Lithium is a mood-stabilizing medicine used most often in bipolar disorder, especially to reduce manic relapse and help prevent future mood episodes. It may also be used in selected cases of recurrent depression or other psychiatric conditions, depending on the clinician’s judgment.
The test does not measure whether mood symptoms are improving directly. It measures exposure to the medicine. That distinction matters because a person can have a “therapeutic” lithium level and still have symptoms, or can feel unwell from side effects even when the result is not technically toxic. The number is one part of treatment monitoring, not the whole story.
Lithium is different from many medicines because clinicians often need blood levels to guide dosing. This is called therapeutic drug monitoring. A broader therapeutic drug monitoring panel may include other medicines with narrow safety margins, but lithium is one of the clearest examples because small changes in kidney function, hydration, sodium balance, or interacting drugs can shift the blood level.
Lithium is cleared mainly through the kidneys. The body handles lithium in ways that overlap with sodium and water balance. When the kidneys conserve sodium or water during dehydration, illness, or certain medication effects, lithium may be retained too. That is why a stable dose can become unsafe during vomiting, diarrhea, fever, heavy sweating, sudden dietary changes, or reduced kidney function.
The result is commonly reported as:
| Unit | Meaning | Practical note |
|---|---|---|
| mmol/L | Millimoles of lithium per liter of blood | Common in many lab reports |
| mEq/L | Milliequivalents of lithium per liter of blood | For lithium, mEq/L and mmol/L are numerically equivalent |
For example, a lithium level of 0.7 mmol/L is the same practical number as 0.7 mEq/L. The lab’s reference interval may vary, but the treating clinician often sets a personal target range based on age, diagnosis, relapse history, side effects, kidney function, and pregnancy status.
Therapeutic Range and Target Levels
Lithium has a narrow therapeutic range. That means the useful level and the harmful level are closer together than with many other medicines. The best target is not identical for every person.
For many adults taking lithium for long-term bipolar maintenance, a common target is about 0.6–0.8 mmol/L. This range often balances relapse prevention with tolerability. Some people who respond well but have side effects may be maintained closer to 0.4–0.6 mmol/L, especially when the clinician decides that a lower level is safer and still effective enough. Others may need 0.8–1.0 mmol/L for a period of time if symptoms persist or relapse occurs at lower levels.
Acute mania, recent relapse, or repeated breakthrough symptoms may lead a psychiatrist to use a higher target than long-term maintenance. Older adults, people with kidney impairment, and people prone to side effects often need lower levels. A result that looks acceptable on a general lab report may still be too high for a frail older person or too low for someone with repeated manic relapse.
| Lithium level | Common interpretation | Important context |
|---|---|---|
| Below 0.4 mmol/L | Often below the usual maintenance range | May be intentional in selected people, but can suggest underdosing, missed doses, or wrong timing |
| 0.4–0.6 mmol/L | Lower maintenance range for some patients | May be used when response is good or side effects limit higher dosing |
| 0.6–0.8 mmol/L | Common long-term maintenance target | Often used for adults newly prescribed lithium or stable on maintenance treatment |
| 0.8–1.0 mmol/L | Higher target range | May be used for relapse, ongoing symptoms, or selected acute treatment situations |
| 1.0–1.2 mmol/L | High therapeutic or near-upper range | Requires careful monitoring and symptom review |
| About 1.5 mmol/L or higher | Toxicity concern | Urgent clinical assessment is often needed, especially with symptoms |
These ranges should not be used to adjust lithium without medical guidance. Lithium dosing depends on the trend, the exact timing of the blood draw, the formulation, the dose schedule, symptoms, and other lab results. A single number drawn at the wrong time can be misleading.
The most useful lithium range is the one tied to a person’s clinical history. For example, someone may remain well for years at 0.6 mmol/L with mild thirst and no tremor. Another person may relapse whenever the level falls below 0.8 mmol/L. A third person may develop confusion, imbalance, or kidney changes at a level that would be tolerated by someone else.
Lithium monitoring is also different from testing for many nutrients or hormones. There is no “optimal wellness” lithium level for people who are not prescribed lithium. The goal is not to push the level higher within the range. The goal is to use the lowest effective level that protects mood while avoiding toxicity and long-term complications.
How and When the Test Is Done
A lithium blood test is a standard blood draw from a vein. The test itself is simple, but the timing is not. Routine lithium monitoring is usually done as a trough level, meaning the sample is taken just before the next dose when the blood level is near its lowest point.
For most once-daily or twice-daily lithium regimens, the routine target is a blood sample about 12 hours after the last dose. If someone takes lithium at 9 p.m., the blood draw is often planned around 9 a.m. the next morning before taking the next dose, unless the prescriber gives different instructions.
A sample drawn too soon after a dose can look falsely high because it may capture the post-dose rise. A sample drawn much later than 12 hours can look lower than the usual trough. The result may then lead to an unnecessary dose change.
Lithium levels are commonly checked:
- About 5–7 days after starting lithium, depending on the formulation and local practice
- About 5–7 days after a dose change
- Weekly or regularly until the level is stable during initiation
- Every 3 months during the first year in many monitoring plans
- Every 3–6 months once stable, depending on risk
- More often during illness, interacting medication changes, pregnancy, kidney changes, poor symptom control, suspected nonadherence, or levels at the higher end of the target range
People should follow the prescriber’s instructions about whether to take the dose before or after the blood draw. In many routine trough checks, the morning dose is delayed until after the sample. Stopping lithium before a test without instructions can create a misleading low level and may raise relapse risk.
Several details help the clinician interpret the result:
- The exact time of the last lithium dose
- The exact time the blood was drawn
- The lithium dose and formulation
- Missed doses in the last week
- Vomiting, diarrhea, fever, heavy sweating, or dehydration
- Any new medicines, especially NSAIDs, diuretics, ACE inhibitors, or angiotensin receptor blockers
- Changes in salt intake, fluid intake, caffeine use, or kidney function
- New symptoms such as tremor, imbalance, confusion, severe thirst, or frequent urination
Lithium levels are usually interpreted after the medicine has reached a steady pattern in the body. Because lithium’s half-life can be longer in older adults and in kidney impairment, some people need extra caution after dose changes. A level that seems fine early after a change may still need follow-up if kidney function is unstable.
High, Low, and Toxic Lithium Results
A low lithium result may mean the dose is not high enough, but it can also mean the blood was drawn too late, doses were missed, the person recently increased caffeine intake, or the treatment plan intentionally uses a low target. Low levels matter most when mood symptoms are returning or when the level has dropped compared with previous stable results.
A high lithium result may mean the dose is too high, the sample was drawn too soon after a dose, kidney function has changed, fluid or sodium balance has shifted, or another medicine is increasing lithium retention. High levels deserve prompt review because toxicity can progress.
Toxicity is not defined by the number alone. Symptoms matter. Some people develop lithium neurotoxicity at levels that appear only mildly elevated, especially with chronic use, older age, kidney impairment, or interacting medicines. Others with an acute ingestion may have a high blood level before lithium has fully moved into tissues, so repeat levels and clinical observation may be needed.
Mild toxicity can include:
- Nausea
- Vomiting
- Diarrhea
- Worsening tremor
- Tiredness
- Muscle weakness
- Dizziness
More serious toxicity can include:
- Coarse tremor
- Unsteady walking or ataxia
- Slurred speech
- Confusion
- Agitation or unusual drowsiness
- Muscle twitching
- Severe weakness
- Falls
- Seizures
- Reduced consciousness
- Abnormal heart rhythm in severe cases
A level around 1.5 mmol/L or higher is often treated as a toxicity warning zone, especially if symptoms are present. Levels above 2.0 mmol/L are more concerning and may require urgent hospital assessment. Levels above 2.5–3.0 mmol/L can be dangerous, particularly with neurological symptoms, kidney impairment, or chronic accumulation.
| Result pattern | Possible meaning | Common next step |
|---|---|---|
| Low level, no symptoms, stable mood | May be acceptable for a person with a lower target | Review timing, adherence, and target range |
| Low level with mood symptoms | Possible underexposure or missed doses | Prescriber may review dose, adherence, and other treatments |
| High level without symptoms | Possible timing issue, interaction, dehydration, or excess dose | Prompt clinician review and often repeat testing |
| High level with vomiting, tremor, confusion, or imbalance | Possible lithium toxicity | Urgent medical assessment; lithium is usually withheld until reviewed |
| Symptoms of toxicity with “normal” level | Toxicity can still occur in some situations | Urgent clinical review, repeat level, and kidney/electrolyte tests |
Do not ignore symptoms because the result is “in range.” A new coarse tremor, confusion, worsening balance, repeated vomiting, or sudden severe weakness in someone taking lithium should be taken seriously. Clinical symptoms can be more important than waiting for a perfect number.
Why Lithium Levels Change
Lithium levels can change even when the dose has not changed. The most common reason is a shift in kidney handling of lithium. Because the kidneys clear lithium, anything that reduces lithium excretion can raise the level.
Dehydration is a common trigger. Vomiting, diarrhea, fever, heavy sweating, poor fluid intake, or prolonged heat exposure can increase lithium concentration. The risk rises further if illness also reduces kidney blood flow. A person who has been stable for months can become toxic during a short gastrointestinal illness.
Sodium balance also matters. A sudden low-salt diet may increase lithium retention in some people. Large changes in fluid intake can also affect results. Lithium users should avoid sudden, extreme changes in salt or fluid habits unless supervised.
Several medicines can increase lithium levels or toxicity risk. Common examples include:
- NSAIDs such as ibuprofen, naproxen, and some prescription anti-inflammatory medicines
- Thiazide diuretics and some other water pills
- ACE inhibitors used for blood pressure or heart conditions
- Angiotensin receptor blockers
- Some medicines that affect kidney function or sodium-water balance
Not every person has the same response, and some interacting drugs can be used safely with careful planning. The danger is starting or stopping them without lithium monitoring. People taking lithium should ask a clinician or pharmacist before using over-the-counter NSAIDs. Acetaminophen/paracetamol is often preferred for pain or fever in many lithium-treated people, but personal medical factors still matter.
Caffeine changes can also affect lithium. Caffeine may increase urine output and can lower lithium levels in some people. A sudden large reduction in caffeine may remove that effect and allow lithium to rise. This does not mean caffeine is required; it means consistency helps. Major changes in coffee, energy drinks, or caffeine tablets are worth mentioning during monitoring.
Kidney function changes are another major cause. A rising creatinine or falling eGFR can reduce lithium clearance. A related article on lithium level and kidney function covers this pattern in more detail, but the basic idea is simple: when kidney filtration falls, lithium may stay in the body longer.
Formulation and brand changes can matter too. Modified-release tablets, immediate-release capsules, and liquid preparations may produce different absorption patterns. In some regions, lithium is prescribed by brand because switching products can change blood levels. Any change in formulation should be treated like a dose change, with follow-up testing when advised.
Missed doses create the opposite problem. A person may have a low result because they skipped lithium for a few days, then restart at the usual dose and become high later if the clinician increases the dose based on the misleading low result. Honest reporting of missed doses is a safety issue, not a judgment issue.
Other Tests Used With Lithium Monitoring
Lithium monitoring is never just a lithium number. Long-term treatment usually includes kidney, thyroid, calcium, electrolyte, and sometimes heart monitoring. These tests help detect risks early, before symptoms become severe.
Kidney tests are central because lithium is cleared through the kidneys and can affect kidney concentrating ability over time. Creatinine and eGFR help estimate filtration. Urea or BUN may help assess kidney function and hydration. If kidney numbers worsen over repeated tests, the lithium level may need closer monitoring, a dose review, or specialist input.
A kidney function blood test panel can help place lithium results in context. For example, a lithium level of 0.9 mmol/L may be more concerning if creatinine is rising than if kidney function has been stable for years. The combination of creatinine and eGFR is often more useful than either number alone.
Electrolytes are also important. Sodium, potassium, chloride, bicarbonate or CO2, and calcium can reveal fluid balance problems, acid-base changes, kidney effects, or endocrine complications. A standard electrolyte panel is often part of routine monitoring, especially after illness or medication changes.
Thyroid testing is usually done because lithium can contribute to hypothyroidism. A rising TSH may signal that the thyroid is working harder to maintain normal hormone levels. Symptoms of hypothyroidism can include fatigue, cold intolerance, constipation, dry skin, weight gain, low mood, and slowed thinking. These symptoms can overlap with depression or medication side effects, so blood testing is useful.
Calcium is monitored because lithium can affect parathyroid regulation and may contribute to high calcium in some long-term users. High calcium may cause thirst, frequent urination, constipation, kidney stones, bone loss, abdominal discomfort, or mental fog. Mild high calcium is sometimes found on routine testing before symptoms are obvious.
A complete blood count may be checked at baseline or as part of broader monitoring. Lithium can raise white blood cell counts in some people, usually without infection. The result should be interpreted in clinical context, especially if fever, inflammation, or other symptoms are present.
An ECG may be recommended before starting lithium in people with cardiovascular disease or risk factors. Lithium can affect heart rhythm or conduction in susceptible people, particularly with toxicity or other electrolyte abnormalities.
Some people also need pregnancy testing or pregnancy-specific monitoring. Lithium use during pregnancy and after delivery requires specialist planning because kidney filtration and fluid balance change during pregnancy, and lithium levels can shift quickly around childbirth. Anyone taking lithium who becomes pregnant or plans pregnancy should contact their prescriber promptly rather than stopping suddenly.
What to Do With Lithium Blood Test Results
The safest response to a lithium result is to interpret it with the prescriber who manages the medication. Do not raise, lower, stop, or restart lithium based only on a lab portal number unless a clinician has already given clear instructions for that exact situation.
For a low result, the first questions are usually practical. Was the blood drawn about 12 hours after the last dose? Were any doses missed? Did the person recently increase caffeine? Has the formulation changed? Are mood symptoms returning? If the level is truly low and symptoms suggest relapse risk, the clinician may adjust the dose or review the wider treatment plan.
For a high result, the same timing questions matter, but safety comes first. The clinician may ask about vomiting, diarrhea, fever, fluid intake, tremor, balance, confusion, new medicines, and kidney symptoms. They may repeat the lithium level, check kidney function and electrolytes, hold one or more doses, or arrange urgent assessment.
For symptoms suggesting toxicity, treat the situation as urgent. Repeated vomiting, severe diarrhea, new confusion, slurred speech, severe tremor, unsteady walking, fainting, seizures, or marked drowsiness should not wait for routine office hours. In many cases, lithium is withheld while urgent blood tests and clinical review are arranged, but the exact plan should come from a medical professional.
People taking lithium can reduce avoidable testing problems by keeping a simple record:
- Dose amount and formulation
- Time of the last dose before each test
- Time of the blood draw
- Missed doses
- New medicines or supplements
- Recent illness, dehydration, or major diet changes
- New symptoms
It also helps to use the same lab timing whenever possible. For example, a person who routinely takes lithium at 9 p.m. and tests at 9 a.m. creates results that are easier to compare over time. A test at 7 a.m. one month and noon the next may still be useful, but the timing difference should be visible to the clinician.
Long-term lithium treatment works best when the blood level, symptoms, and safety labs are followed together. A comprehensive metabolic panel can sometimes capture kidney, electrolyte, calcium, and liver-related information in one blood draw, though lithium-specific monitoring still requires the separate lithium level. A comprehensive metabolic panel may be part of broader follow-up when clinicians want a wider snapshot of body chemistry.
Lithium is not a medicine to manage casually, but it is also not a medicine to fear when monitoring is done carefully. Many serious problems are preventable when people know their target range, test at the right time, keep hydration and salt intake consistent, report illness early, avoid unplanned interacting medicines, and act quickly when toxicity symptoms appear.
References
- Bipolar disorder: assessment and management 2025 (Guideline)
- Lithium monitoring 2024 (Guidance)
- Lithium: current state of the art and future directions 2024 (Review)
- Long-term lithium therapy and risk of chronic kidney disease, hyperparathyroidism and hypercalcemia: a cohort study 2023 (Cohort Study)
- What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium 2019 (Systematic Review)
- Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup 2015 (Systematic Review)
Disclaimer
Lithium results should be interpreted by the clinician who prescribed the medication, especially because timing, kidney function, symptoms, and interacting medicines can change the meaning of the number. Seek urgent medical care for possible lithium toxicity symptoms such as repeated vomiting, severe diarrhea, confusion, slurred speech, severe tremor, unsteady walking, seizures, or marked drowsiness. Do not change or stop lithium without medical guidance unless emergency clinicians instruct you to do so.
